SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending as the launch of their fibromyalgia drug, TONMYA, nears, with discussions focusing on its potential impact and market penetration. The community is debating the significance of institutional ownership and analyzing the company's financial health in relation to the upcoming commercial execution. Anticipation of revenue generation and a possible short squeeze are also fueling interest.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is trending due to recent earnings report indicating a 50% YoY revenue increase and record customer growth, although margins were pressured by higher delivery expenses. Community discussion revolves around the impressive revenue numbers and store expansion, with some expressing concern over margin decline and a lack of updates regarding a potential US relisting. Overall, while growth is undeniable, the sustainability of margins and potential catalysts like relisting are key talking points.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as investors discuss Berkshire Hathaway's recent $4.3 billion stake in the company, signaling confidence in Google's AI initiatives. Community chatter revolves around GOOG's potential to outperform competitors in the AI race and its relatively low valuation compared to other tech giants.  Some traders are also noting the potential impact of Google's new AI chip, Ironwood, on the competitive landscape.

Zymeworks, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Its product includes Zanidatamab, which is a novel bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Zanidatamab's unique binding properties result in multiple mechanisms of action that may enable it to address unmet need in patient populations with HER2-expressing cancers. The company was founded on September 8, 2003 and is headquartered in Middletown, DE.

Zymeworks BC Inc

Zymeworks Inc

ZYME is trending following positive Phase 3 trial results for their cancer treatment Ziihera, developed in partnership with Jazz Pharmaceuticals. The community is discussing the potential impact on HER2-positive cancers and the financial implications for both ZYME and Jazz. Some traders caution about low trading volume and the potential risks of getting in now.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to the announcement of a $250 million share repurchase program, sparking bullish sentiment among investors. The community is discussing whether this buyback will trigger a short squeeze, especially given the company's strong balance sheet. Some believe the stock is undervalued and see this as a positive sign, while others are skeptical.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPEV is trending due to positive developments in AI and robotics, including the unveiling of its 'Iron' humanoid robot, and expansion into new European markets. Community discussions revolve around the company's potential to surpass Tesla in robotics and its attractive valuation relative to its growth and innovation. Upcoming earnings are also a key point of interest, with investors anticipating strong results.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium ($SGML) is trending amid discussions around lithium prices, production capacity, and potential takeover scenarios. Community members are analyzing the impact of fluctuating lithium prices on the company's future earnings and debating whether recent price movements signal a potential sector recovery, while also noting insider buying activity. Some traders discuss technical indicators and potential short squeezes, while cautioning of continued volatility given recent price action.

Grindr, Inc. engages in the operation of a social media network application for the gay, bi, trans, queer, and other members of the LGBTQ+ community. The company was founded in 2009 and is headquartered in West Hollywood, CA.

Grindr Inc - Ordinary Shares - Class A

Grindr Inc

Grindr is trending amid buyout speculation, with community members debating the likelihood of a deal and potential premium. Discussions also involve insider selling and its impact on a possible acquisition. Despite the uncertainty, some believe GRND is undervalued, citing strong earnings and analyst price targets.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

Wasatch Pharmaceutical Inc

Wasatch Pharmaceutical (WSHP) is trending due to its recent direct listing, with the community actively discussing potential entry points and watching for chart patterns. Some traders are pointing to the stock as a possible sympathy play, while others urge caution, calling it a scam.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors anticipate upcoming earnings, with analysts predicting a beat-and-raise report due to strong AI demand, despite some concerns about valuation and recent news of Peter Thiel selling his stake. The community is actively debating whether Nvidia can maintain its growth trajectory and if the AI sector is overheated, while also watching for any impact from potential trade deals or government regulations. Bullish sentiment remains strong with many anticipating a market rally if Nvidia delivers positive results and guidance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Heads up alert! Only three days until Upcoming earnings on Monday, 8/4/2025 for $SPNT 
Neutral (5.4) 
Financial Analysis of SiriusPoint (SPNT): 
SiriusPoint Ltd. 
(SPNT), a global insurance underwriter, has recently garnered attention due to its significant stock movement and potential upside. 
Analysts have forecasted a 29.4% upside potential for the stock, driven primarily by upward trends in earnings estimate revisions. 
However, the company faces challenges as it is expected to report a decline in earnings in its upcoming report. 
The current P/E ratio stands at a competitive level compared to industry peers, indicating that the stock might be undervalued. 
While EPS growth has shown variability, recent analyst coverage with a &quot;&quot;Buy&quot;&quot; rating and a price target of $33 reflects confidence in the company&#39;s future performance. 
Revenue forecasts suggest a modest growth trajectory, but the company&#39;s ability to meet or exceed these expectations remains a critical factor for investors. 
Compared to peers in the insurance industry, SiriusPoint&#39;s financial metrics indicate a stable position, though with less robust growth compared to some competitors. 
 
Upcoming Earnings Report: 
SiriusPoint is scheduled to release its second-quarter 2025 earnings results on August 4, 2025. 
Historically, the company has shown mixed performance in earnings, with occasional beats and misses. 
Analyst consensus estimates suggest a cautious outlook, with expectations of a decline in earnings. 
The report&#39;s outcome could significantly impact the stock, especially if actual results deviate from expectations. 
Investors should closely watch the company&#39;s strategic initiatives and management commentary for insights into future performance. 
 
Sector Performance: 
The insurance sector, to which SiriusPoint belongs, has experienced varied performance recently. 
While some companies have reported strong earnings growth and stock appreciation, others have faced challenges related to macroeconomic conditions and competitive pressures. 
SiriusPoint&#39;s sector peers have generally shown resilience, but the overall performance has been influenced by factors such as interest rate changes, regulatory developments, and evolving market dynamics. 
Investors should consider these broader sectoral trends when evaluating SiriusPoint&#39;s potential. 
 
- Funds were net buyers of $SPNT during the previous reporting quarter. 
 
- Funds with large holdings in $SPNT include: 
 
- Donald Smith &amp; Co Inc, MV: $134MM. Fund Rank: 95% 
 
- Gilder Gagnon Howe &amp; Co LLC , MV: $60MM. Fund Rank: 88% 
www3.gghc.com 
- Atika Capital Management LLC, MV: $7MM. New position. Fund Rank: 57% 
www.atikacapital.com 
- Arbiter Partenrs Capital Management LLC, MV: $4MM. Fund Rank: 89% 
www.arbiterpartners.net 
- Soros Fund Management LLC, MV: $2MM. New position. Fund Rank: 55% 
 
- Last 10 days performance: 1% 
- Last 30 days performance: 1% 
- Last 90 days performance: 9% 
 
Some of the latest news articles: 
 - Title: Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High? 
Publication Date: 7/31/2025 1:55:02 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/wall-street-analysts-see-29-135502565.html?.tsrc=rss 
 
 - Title: Radian (RDN) Beats Q2 Earnings Estimates 
Publication Date: 7/30/2025 10:05:03 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/radian-rdn-beats-q2-earnings-220503366.html?.tsrc=rss 
 
 - Title: Equitable Holdings, Inc. (EQH) Expected to Beat Earnings Estimates: Should You Buy? 
Publication Date: 7/29/2025 2:00:23 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/equitable-holdings-inc-eqh-expected-140023197.html?.tsrc=rss 
 
 - Title: Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for 
Publication Date: 7/28/2025 2:00:16 PM, Source: yahoo 
URL: https://finance.yahoo.com/news/analysts-estimate-siriuspoint-spnt-report-140016787.html?.tsrc=rss 
 
Follow us on stocktwits.com and Substack (chessgmstocks.substack.com). Not a financial advice. Not a trading signal.

Richard Gilder buys a seat on the New York Stock Exchange and starts R. Gilder and Co., a brokerage firm focused on discretionary growth investing for individual investors. Located near Central Park at 3 Columbus Circle, the firm opens its doors undertaking its own clearing (back office), with over 50 employees and about $25 million under management.

Gilder Gagnon Howe & Co. LLC

Atika Capital

HOME | Atika Capital

Arbiterpartners

Arbiter Partners

The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo Finance

Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High?

Radian (RDN) delivered earnings and revenue surprises of +8.60% and -1.53%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Radian (RDN) Beats Q2 Earnings Estimates

Equitable Holdings (EQH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Equitable Holdings, Inc. (EQH) Expected to Beat Earnings Estimates: Should You Buy?

SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for

Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.

Stocktwits

Stocktwits - Stock Market Live Quotes, Social Community Discussions, News, Stock Rankings & Earnings

We are full-time investors. We use AI, prop tech, and data to make predictive stock trade decisions. We aim to make an educated call based on data. We do not provide a trading signal nor do we offer a financial advice. Please do your own DD.

Substack

EDGR's Substack | ChessGM | Substack

StockTwits Web

SiriusPoint Ltd

Heads up alert! Only three days until Upcoming earnings on Monday, 8/4/2025 for 

 
Neutral (5.4) 
Financial Analysis of SiriusPoint (SPNT): 
SiriusPoint Ltd. 
(SPNT), a global insurance underwriter, has recently garnered attention due to its significant stock movement and potential upside. 
Analysts have forecasted a 29.4% upside potential for the stock, driven primarily by upward trends in earnings estimate revisions. 
However, the company faces challenges as it is expected to report a decline in earnings in its upcoming report. 
The current P/E ratio stands at a competitive level compared to industry peers, indicating that the stock might be undervalued. 
While EPS growth has shown variability, recent analyst coverage with a ""Buy"" rating and a price target of $33 reflects confidence in the company's future performance. 
Revenue forecasts suggest a modest growth trajectory, but the company's ability to meet or exceed these expectations remains a critical factor for investors. 
Compared to peers in the insurance industry, SiriusPoint's financial metrics indicate a stable position, though with less robust growth compared to some competitors. 
 
Upcoming Earnings Report: 
SiriusPoint is scheduled to release its second-quarter 2025 earnings results on August 4, 2025. 
Historically, the company has shown mixed performance in earnings, with occasional beats and misses. 
Analyst consensus estimates suggest a cautious outlook, with expectations of a decline in earnings. 
The report's outcome could significantly impact the stock, especially if actual results deviate from expectations. 
Investors should closely watch the company's strategic initiatives and management commentary for insights into future performance. 
 
Sector Performance: 
The insurance sector, to which SiriusPoint belongs, has experienced varied performance recently. 
While some companies have reported strong earnings growth and stock appreciation, others have faced challenges related to macroeconomic conditions and competitive pressures. 
SiriusPoint's sector peers have generally shown resilience, but the overall performance has been influenced by factors such as interest rate changes, regulatory developments, and evolving market dynamics. 
Investors should consider these broader sectoral trends when evaluating SiriusPoint's potential. 
 
- Funds were net buyers of 

 during the previous reporting quarter. 
 
- Funds with large holdings in 

 include: 
 
- Donald Smith & Co Inc, MV: $134MM. Fund Rank: 95% 
 
- Gilder Gagnon Howe & Co LLC , MV: $60MM. Fund Rank: 88% 


 
- Atika Capital Management LLC, MV: $7MM. New position. Fund Rank: 57% 


 
- Arbiter Partenrs Capital Management LLC, MV: $4MM. Fund Rank: 89% 


 
- Soros Fund Management LLC, MV: $2MM. New position. Fund Rank: 55% 
 
- Last 10 days performance: 1% 
- Last 30 days performance: 1% 
- Last 90 days performance: 9% 
 
Some of the latest news articles: 
 - Title: Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High? 
Publication Date: 7/31/2025 1:55:02 PM, Source: yahoo 
URL: 

 
 
 - Title: Radian (RDN) Beats Q2 Earnings Estimates 
Publication Date: 7/30/2025 10:05:03 PM, Source: yahoo 
URL: 

 
 
 - Title: Equitable Holdings, Inc. (EQH) Expected to Beat Earnings Estimates: Should You Buy? 
Publication Date: 7/29/2025 2:00:23 PM, Source: yahoo 
URL: 

 
 
 - Title: Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for 
Publication Date: 7/28/2025 2:00:16 PM, Source: yahoo 
URL: 

). Not a financial advice. Not a trading signal.